Significant strides have been made in leveraging checkpoint inhibitor therapy to combat a number of cancers over the recent years. However, not all malignancies…
LIXTE recently expanded its ovarian clear cell cancer trial in partnership with MD Anderson and GSK The company operates at…
California, led by Democratic governor Gavin Newsom, has decided to break with the federal positions on public health and has resolved to stand by…
Earth Science Tech is a holding company that acquires and manages businesses in several markets, emphasizing execution, capital discipline, and…
Prof. Brown is a leading researcher in Transcranial Magnetic Stimulation (“TMS”) and currently serves as President of the Clinical TMS…
South Korean scientists have published the results of a study that provides vital insights indicating that brain cancer develops much…
LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients…
“The EMA's positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO.…
The company’s core innovation, the HeartBeam System, is positioned as the first cable-free, high-fidelity ECG system capable of capturing the…
Oregon State University researchers have engineered a new nanomaterial from iron that kills cancer cells inside tumors and leaves normal cells unaffected. This…